Austin Gerard Smith

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 19:03, 21 October 2016 (Rescuing 1 sources and tagging 1 as dead. #IABot (v1.2.5)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Austin Smith
Born
Austin Gerard Smith

1960 (age 63–64)
Merseyside, United Kingdom [2]
NationalityUnited Kingdom
CitizenshipUnited Kingdom
Alma materUniversity of Edinburgh
AwardsLouis-Jeantet Prize for Medicine [1]
Scientific career
FieldsStem Cells
InstitutionsUniversity of Cambridge
Thesis (1986)
Doctoral advisorMartin Hooper[citation needed]
Websitewww.stemcells.cam.ac.uk/researchers/principal-investigators/pressor-austin-smith[3]

Austin Gerard Smith (born 1960) is a professor in the Department of Biochemistry and director of the Wellcome Trust Centre for Stem Cell Research at the University of Cambridge.[3] He is notable for his pioneering work on the biology of embryonic stem cells.[4][5]

Education

Austin Smith obtained his doctoral degree from the University of Edinburgh in 1986.[3]

Career and research

He then carried out postdoctoral research at the University of Oxford, before joining the Centre for Genome Research at the University of Edinburgh as a group leader.[3] In 1996, he was appointed director of the Centre, which became the Institute for Stem Cell Research under his leadership.[3] He remained as director of the Institute until his move to Cambridge in 2006.[6]

In 2003, Smith was awarded an MRC Research Professorship[3] and elected to the Royal Society of Edinburgh.[7] And in 2006, was elected a Fellow of the Royal Society.[8] In 2010, he was co-recipient of the Louis-Jeantet Prize for Medicine along with French cardiologist Michel Haissaguerre.[1]

In February 2010, together with 13 other leading stem cell researchers, he wrote an open letter to journal editors to voice the opinion that obstructive reviews by a small number of researchers in the field were hindering publication of novel stem cell research.[9] [10]

Austin Smith will be the director of the new Wellcome Trust-MRC Cambridge Stem Cell Institute at the University of Cambridge, which will be established with 8 million pounds ($12.5 million) awarded by the Wellcome Trust and Medical Research Council (UK) in 2012.[11]

References

  1. ^ a b http://www.eurekalert.org/pub_releases/2010-01/embo-2lp012510.php
  2. ^ http://www.jeantet.ch/e/winners/smith-austin.htm[permanent dead link]
  3. ^ a b c d e f http://www.stemcells.cam.ac.uk/researchers/principal-investigators/pressor-austin-smith
  4. ^ "The Stars of Europe – Innovators: Austin Smith, Director, Centre for Genome Research". Businessweek. 17 June 2002. Archived from the original on 2008-05-31. {{cite news}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  5. ^ "New Safer Way Developed To Reprogram Stem Cells". Science Daily. 3 March 2009.
  6. ^ "Stage set for world-leading stem cell research centre". Wellcome Trust. Retrieved 5 September 2012.
  7. ^ "RSE Fellows as at 12/04/2011" (PDF). Royal Society of Edinburgh. Archived from the original (PDF) on 17 May 2011. Retrieved 26 April 2011. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  8. ^ "Fellows". Royal Society. Archived from the original on 30 November 2010. Retrieved 4 December 2010. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  9. ^ "Open letter to Senior Editors of peer-review journals publishing in the field of stem cell biology". Retrieved 5 September 2012.
  10. ^ Ghosh, Pallab (2 February 2010). "Journal stem cell work 'blocked'". BBC News.
  11. ^ "Cambridge Joins Harvard In Opening Stem-Cell Institute". Bloomberg News. 8 August 2012.